SE457505B - Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning - Google Patents

Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning

Info

Publication number
SE457505B
SE457505B SE8400085A SE8400085A SE457505B SE 457505 B SE457505 B SE 457505B SE 8400085 A SE8400085 A SE 8400085A SE 8400085 A SE8400085 A SE 8400085A SE 457505 B SE457505 B SE 457505B
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
layer
active substance
copolymer
amount
Prior art date
Application number
SE8400085A
Other languages
English (en)
Swedish (sv)
Other versions
SE8400085D0 (sv
SE8400085L (sv
Inventor
C H Appelgren
C Eskilsson
Original Assignee
Lejus Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20354249&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE457505(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of SE8400085D0 publication Critical patent/SE8400085D0/xx
Priority to SE8400085A priority Critical patent/SE457505B/sv
Application filed by Lejus Medical Ab filed Critical Lejus Medical Ab
Priority to AT88850123T priority patent/ATE77077T1/de
Priority to EP88850123A priority patent/EP0293347B1/fr
Priority to EP85850007A priority patent/EP0148811B1/fr
Priority to DE8585850007T priority patent/DE3572767D1/de
Priority to AT85850007T priority patent/ATE46080T1/de
Priority to DE8888850123T priority patent/DE3586206T2/de
Priority to US06/690,197 priority patent/US4780318A/en
Publication of SE8400085L publication Critical patent/SE8400085L/xx
Priority to SE8600202A priority patent/SE462529B/sv
Priority to US07/172,897 priority patent/US5001161A/en
Publication of SE457505B publication Critical patent/SE457505B/sv
Priority to US07/590,237 priority patent/US5081154A/en
Priority to SG2295A priority patent/SG2295G/en
Priority to HK24995A priority patent/HK24995A/xx
Priority to LV960257A priority patent/LV5814B4/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8400085A 1984-01-10 1984-01-10 Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning SE457505B (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE8400085A SE457505B (sv) 1984-01-10 1984-01-10 Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
AT88850123T ATE77077T1 (de) 1984-01-10 1985-01-08 Metoprololsuccinat und dieses enthaltende pharmazeutische zusammensetzung.
EP88850123A EP0293347B1 (fr) 1984-01-10 1985-01-08 Succinate de métoprolol et composition pharmaceutique le contenant
EP85850007A EP0148811B1 (fr) 1984-01-10 1985-01-08 Composition pharmaceutique
DE8585850007T DE3572767D1 (en) 1984-01-10 1985-01-08 Pharmaceutical composition
AT85850007T ATE46080T1 (de) 1984-01-10 1985-01-08 Pharmazeutische komposition.
DE8888850123T DE3586206T2 (de) 1984-01-10 1985-01-08 Metoprololsuccinat und dieses enthaltende pharmazeutische zusammensetzung.
US06/690,197 US4780318A (en) 1984-01-10 1985-01-10 Oral pharmaceutical composition
SE8600202A SE462529B (sv) 1984-01-10 1986-01-17 Metoprololsuccinat samt farmaceutisk komposition innehaallande detsamma
US07/172,897 US5001161A (en) 1984-01-10 1988-03-25 Pharmaceutical composition comprising metroprolol succinate
US07/590,237 US5081154A (en) 1984-01-10 1990-09-28 Metoprolol succinate
SG2295A SG2295G (en) 1984-01-10 1995-01-09 Metropolol succinate and pharmaceutical composition containing it
HK24995A HK24995A (en) 1984-01-10 1995-02-23 Metoprolol succinate and pharmaceutical composition containing it
LV960257A LV5814B4 (lv) 1984-01-10 1996-07-17 Metoprolola sukcinats

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8400085A SE457505B (sv) 1984-01-10 1984-01-10 Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning

Publications (3)

Publication Number Publication Date
SE8400085D0 SE8400085D0 (sv) 1984-01-10
SE8400085L SE8400085L (sv) 1985-07-11
SE457505B true SE457505B (sv) 1989-01-09

Family

ID=20354249

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8400085A SE457505B (sv) 1984-01-10 1984-01-10 Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
SE8600202A SE462529B (sv) 1984-01-10 1986-01-17 Metoprololsuccinat samt farmaceutisk komposition innehaallande detsamma

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8600202A SE462529B (sv) 1984-01-10 1986-01-17 Metoprololsuccinat samt farmaceutisk komposition innehaallande detsamma

Country Status (7)

Country Link
US (2) US4780318A (fr)
EP (2) EP0293347B1 (fr)
AT (2) ATE46080T1 (fr)
DE (2) DE3586206T2 (fr)
HK (1) HK24995A (fr)
SE (2) SE457505B (fr)
SG (1) SG2295G (fr)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
JPS57500432A (fr) * 1980-03-20 1982-03-11
JPS6261916A (ja) * 1985-09-12 1987-03-18 Fujisawa Pharmaceut Co Ltd 持続性製剤
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
US4717567A (en) * 1985-11-25 1988-01-05 Eastman Kodak Company Rumen-stable pellets
GB2186485B (en) * 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
AU591248B2 (en) * 1986-03-27 1989-11-30 Kinaform Technology, Inc. Sustained-release pharaceutical preparation
US5238686A (en) * 1986-03-27 1993-08-24 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
EP0294493A4 (fr) * 1986-12-25 1989-07-24 Teysan Pharmaceuticals Co Ltd Granule a dissolution lente et granule composite a effet persistant prepare a partir du premier granule.
SE460945B (sv) * 1987-01-15 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av furosemid
US4789549A (en) * 1987-03-09 1988-12-06 Warner-Lambert Company Sustained release dosage forms
SE460946B (sv) * 1987-03-16 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av kinidinglukonat
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
IL88083A (en) * 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
FI101344B1 (fi) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
FR2634376B1 (fr) * 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
JPH0273011A (ja) * 1988-07-28 1990-03-13 Warner Lambert Co 医薬投与剤型製造用のセルロースおよびアクリル系重合体の水性重合体分散体およびその投与剤型
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
GB8913889D0 (en) * 1989-06-16 1989-08-02 May & Baker Ltd New compositions of matter
US5422881A (en) * 1989-06-30 1995-06-06 Inmos Limited Message encoding
GB8915137D0 (en) * 1989-06-30 1989-08-23 Inmos Ltd Message routing
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
EP0458751A1 (fr) * 1990-05-25 1991-11-27 Warner-Lambert Company Système à libération d'amino-acides cycliques avec gôut, texture et compressibilité améliorés
DK0540670T3 (da) * 1990-07-26 1996-04-29 Monsanto Co Fremgangsmåde til fremstilling af tværbundne polyaminer
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
WO1994003160A1 (fr) * 1992-08-05 1994-02-17 F.H. Faulding & Co. Limited Composition pharmaceutique sous forme de granules
AU5376894A (en) * 1992-11-06 1994-06-08 Hisamitsu Pharmaceutical Co., Inc. Peroral pharmaceutical preparation releasable in lower digestive tract
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
ATE195252T1 (de) * 1993-04-23 2000-08-15 Novartis Erfind Verwalt Gmbh Wirkstoffabgabevorrichtung mit gesteuerter freigabe
DE4329503A1 (de) * 1993-09-01 1995-03-02 Galenik Labor Freiburg Gmbh Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa
US6204243B1 (en) 1993-09-01 2001-03-20 Novatis Ag Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
US6039975A (en) * 1995-10-17 2000-03-21 Hoffman-La Roche Inc. Colon targeted delivery system
DK0871434T4 (da) * 1995-12-21 2008-04-07 Ferring Farma Lab Oralt farmaceutisk sammensætning med modificeret frigivelse indeholdende 5-ASA og fremgangsmåde til behandling af tarmsygdomme
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
DE19845358A1 (de) * 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
AU764469B2 (en) 1999-01-29 2003-08-21 Disphar International B.V. Pharmaceutical compositions
AU8531101A (en) 2000-08-29 2002-03-13 Nobex Corp Immunoregulatory compounds and derivatives and methods of treating diseases therewith
CA2359812C (fr) 2000-11-20 2004-02-10 The Procter & Gamble Company Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures
US6610326B2 (en) * 2001-02-16 2003-08-26 Andrx Corporation Divalproex sodium tablets
US20040105886A1 (en) * 2001-02-16 2004-06-03 Chih-Ming Chen Divalproex sodium tablets
JP5005157B2 (ja) * 2001-03-13 2012-08-22 ペンウェスト ファーマシューティカルズ カンパニー 時間治療（ｃｈｒｏｎｏｔｈｅｒａｐｅｕｔｉｃ）投与形態
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
US6500454B1 (en) * 2001-10-04 2002-12-31 Eurand Pharmaceuticals Ltd. Timed, sustained release systems for propranolol
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
AR036797A1 (es) 2001-10-15 2004-10-06 Ferring Bv Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
BR0306726A (pt) * 2002-01-07 2004-12-21 Pharmacia Corp Mistura de fármacos com melhor taxa de dissolução
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
MXPA04009701A (es) * 2002-04-05 2005-05-27 Penwest Pharmaceuticals Co Formulaciones de metoprolol de liberacion sostenida.
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
AU2003282375A1 (en) * 2003-02-05 2004-08-30 Ipca Laboratories Limited Pharmaceutical compositions and process of production thereof
JP2007523664A (ja) 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050032879A1 (en) * 2003-08-07 2005-02-10 Temple Okarter Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases
MXPA06003101A (es) * 2003-09-19 2006-06-20 Penwest Pharmaceuticals Co Formas de dosis cronoterapeuticas.
WO2005027878A1 (fr) * 2003-09-19 2005-03-31 Penwest Pharmaceuticals Co. Formes posologiques a liberation retardee
EP1547601A1 (fr) 2003-12-23 2005-06-29 Ferring B.V. Procédé de revêtement
US20060003001A1 (en) * 2004-02-11 2006-01-05 John Devane Chronotherapeutic compositions and methods of their use
DK1773767T3 (en) 2004-07-07 2016-03-21 Biocon Ltd Synthesis of azo bound in immune regulatory relations
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ728442A (en) 2004-10-21 2018-05-25 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US20070087056A1 (en) * 2005-08-09 2007-04-19 Claudia Guthmann Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
US20070053983A1 (en) * 2005-09-06 2007-03-08 Girish Jain Extended release compositions of metoprolol succinate
EP1971570A2 (fr) * 2005-12-23 2008-09-24 Medichem, S.A. Procede de preparation du metoprolol et de ses sels
US20090028944A1 (en) * 2007-07-16 2009-01-29 Balaji Sathurappan Pharmaceutical compositions comprising mesalamine
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
US20090062191A1 (en) * 2007-08-29 2009-03-05 Kiel Laboratories, Inc. Composition for maintaining gastrointestinal homeostasis
US20090214665A1 (en) * 2008-02-26 2009-08-27 Lai Felix S Controlled Release Muscarinic Receptor Antagonist Formulation
EA022886B1 (ru) 2008-10-03 2016-03-31 Др. Фальк Фарма Гмбх Способ поддержания ремиссии язвенного колита у пациентов
PL2255791T3 (pl) 2009-04-03 2012-05-31 Zakl Farmaceutyczne Polpharma Sa Kompozycja farmaceutyczna o przedłużonym uwalnianiu zawierająca bursztynian metoprololu
CN102008457B (zh) * 2009-09-04 2014-04-02 北京天衡药物研究院 酒石酸美托洛尔骨架缓释片
MX2012006240A (es) 2009-12-02 2012-10-03 Aptalis Pharma Ltd Microcapsulas de fexofenadina y composiciones que contienen las mismas.
IL210279A0 (en) 2009-12-25 2011-03-31 Dexcel Pharma Technologies Ltd Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2099402A (en) * 1934-01-17 1937-11-16 Pratt Food Company Pill or tablet
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
DE1204363B (de) * 1963-09-10 1965-11-04 Hoffmann La Roche Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt
NL130749C (fr) * 1964-09-10
US3483221A (en) * 1964-09-10 1969-12-09 Ciba Geigy Corp 1 - (isopropylamino)-2-hydroxy-3-(alkenyloxyphenoxy) - propanes and the salts thereof
AT270071B (de) * 1966-08-12 1969-04-10 Roehm & Haas Gmbh Dragierlack für Arzneiformen
US3629237A (en) * 1968-09-12 1971-12-21 Shinetsu Chemical Co Compositions useful as enteric coatings and method for preparing acid phthalates of cellulose ethers for them
SE384853B (sv) * 1972-04-04 1976-05-24 Haessle Ab Forfarande for framstellning av nya aminer
SE354851B (fr) * 1970-02-18 1973-03-26 Haessle Ab
US3909444A (en) * 1971-08-05 1975-09-30 Ncr Co Microcapsule
US4145442A (en) * 1972-04-04 1979-03-20 Aktiebolaget Hassle Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases
ZA739543B (en) * 1973-02-16 1975-03-26 Hoffmann La Roche Free-flowing, directly tablettable, pharmaceutically active substances
JPS5518694B2 (fr) * 1973-04-02 1980-05-21
GB1413186A (en) * 1973-06-27 1975-11-12 Toyo Jozo Kk Process for encapsulation of medicaments
SE385693B (sv) * 1973-10-08 1976-07-19 Haessle Ab Forfarande for framstellning av nya aminer
SE388849B (sv) * 1974-02-14 1976-10-18 Haessle Ab Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan
JPS5512411B2 (fr) * 1974-03-12 1980-04-02
ZA754241B (en) * 1974-11-01 1976-06-30 Haessle Ab New amines
SE402765B (sv) * 1975-06-04 1978-07-17 Haessle Ab Forfarande for framstellning av en ny hjertaktiv forening
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
DE2645710C2 (de) * 1976-10-09 1985-06-27 Merck Patent Gmbh, 6100 Darmstadt Phenoxy-amino-propanole, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung
US4218433A (en) * 1977-03-03 1980-08-19 Nippon Kayaku Kabushiki Kaisha Constant-rate eluting tablet and method of producing same
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
DE2905134A1 (de) * 1978-02-17 1979-08-23 Degussa Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest
SE426548B (sv) * 1978-12-05 1983-01-31 Haessle Ab Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer
GB2051574B (en) * 1979-05-10 1984-01-18 Kyoto Pharma Ind Adjuvant for promoting absorption of pharmacologically active substances through the rectum
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
EP0064485B1 (fr) * 1981-04-27 1985-07-24 Aktiebolaget Hässle Préparation pharmaceutique
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3208791A1 (de) * 1982-03-11 1983-09-22 Röhm GmbH, 6100 Darmstadt Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels
EP0094117A3 (fr) * 1982-05-06 1984-08-01 The Procter & Gamble Company Granulés thérapeutiques
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
JPS5920219A (ja) * 1982-07-26 1984-02-01 Shin Etsu Chem Co Ltd 腸溶性コ−テイング製剤の製造方法
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4627850A (en) * 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
WO1985002092A1 (fr) * 1983-11-14 1985-05-23 Bio-Mimetics Inc. Compositions bio-adhesives et procedes de traitement a l'aide de celles-ci
US4623588A (en) * 1984-02-06 1986-11-18 Biotek, Inc. Controlled release composite core coated microparticles
DE3405378A1 (de) * 1984-02-15 1985-08-22 Röhm GmbH, 6100 Darmstadt Arzneimittelueberzug

Also Published As

Publication number Publication date
US5001161A (en) 1991-03-19
EP0148811B1 (fr) 1989-09-06
US4780318A (en) 1988-10-25
SE462529B (sv) 1990-07-09
SE8400085D0 (sv) 1984-01-10
EP0293347A1 (fr) 1988-11-30
EP0293347B1 (fr) 1992-06-10
EP0148811A1 (fr) 1985-07-17
HK24995A (en) 1995-03-03
DE3586206D1 (de) 1992-07-16
SE8600202D0 (sv) 1986-01-17
ATE46080T1 (de) 1989-09-15
DE3572767D1 (en) 1989-10-12
SE8600202L (sv) 1986-01-17
DE3586206T2 (de) 1992-12-24
ATE77077T1 (de) 1992-06-15
SG2295G (en) 1995-06-16
SE8400085L (sv) 1985-07-11

Similar Documents

Publication Publication Date Title
SE457505B (sv) Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
EP1117387B1 (fr) Formes medicamenteuses enrobees a liberation controlee du principe actif
KR100316206B1 (ko) 모르핀의염을함유하는방출조절식제제
KR940000098B1 (ko) 유효 화합물을 서서히 방출하는 신규 제제의 제조방법
JP4172917B2 (ja) 急速に効果を発揮し且つ効果的な血漿薬物濃度が急速に低下する制御放出性製剤
JP3902229B2 (ja) 結腸デリバリー用の、多腸溶ポリマー被覆物を有する医薬投与形態
US5229135A (en) Sustained release diltiazem formulation
US5175003A (en) Dual mechanism controlled release system for drug dosage forms
EP1023896B1 (fr) Formulations d' opioides pour le traitement de la douleur
DK174949B1 (da) Formuleringer med forlænget frigivelse og deres fremstilling
RU2111743C1 (ru) Многокомпонентная дозированная форма с контролируемым выделением активного ингредиента
SE455836B (sv) Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
JP2004512296A (ja) メチルフェニデート改変放出製剤
BR9914977B1 (pt) Composição multiparticulada de liberação modificada
BG65398B1 (bg) Ентерично покрит фармацевтичен състав и метод за получаване
CA2071319A1 (fr) Preparation buccale a base de diclofenac
US20060039997A1 (en) Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
JPS647047B2 (fr)
SE447871B (sv) Farmaceutisk komposition med lang utsondringstid innefattande pinacidil i minst tva olika typer av pelletar
US7041317B2 (en) Sustained-release preparation containing 5-acetyl-4,6-dimethyl-2[2-[4-(2-methoxyphenyl) piperazinyl]ethylamino] pyrimidine trihydrochloride as active ingredient
EP0796089A1 (fr) Formulation d'hydrochlorure de diltiazem
KR940008415B1 (ko) 코팅 막과 그로부터 제조된 조성물
FI102455B (fi) Menetelmä oraalisen farmaseuttisen moniyksikköformulaation valmistamis eksi
MXPA97010305A (en) Procedure for preparing the composition of prolonged action of granules containing 4-nitro-2-fenoximetanosulfonanil
MXPA99000903A (en) Tramadol multiple unit formulations

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8400085-0

Effective date: 19920806

Format of ref document f/p: F